期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Chinese Prescription Kangen-karyu against Metabolic Syndrome:Successful Treatment of Three Patients
1
作者 Tsutomu Kitazawa Kazuyuki Hiratani +1 位作者 Chan Hum Park Takako Yokozawa 《Journal of Integrative Medicine(双语)》 2021年第1期56-62,共7页
Metabolic syndrome is the cluster of diseases,which is manifested by central obesity,impaired glucose tolerance,lipodystrophy,and high blood pressure.These metabolic syndrome-related traits significantly increase the ... Metabolic syndrome is the cluster of diseases,which is manifested by central obesity,impaired glucose tolerance,lipodystrophy,and high blood pressure.These metabolic syndrome-related traits significantly increase the risk of type 2 diabetes,adverse cardiac events,stroke,and hepatic steatosis.In the past decade,several organizations have proposed different diagnostic criteria.The use of traditional Chinese medicine to treat metabolic syndrome has received increasing attention due to its wide availability.In this paper,we report a case of three patients with metabolic syndrome with improved administration of 7.5 g of Kangen-karyu extract per day for 6 months.We present and discuss evidence supporting the possibility of using Kangenkaryu for metabolic syndrome. 展开更多
关键词 Metabolic syndrome Traditional Chinese medicine kangen-karyu Case report
下载PDF
Chinese Prescription Kangen-karyu as Potential Anti-Alzheimer’s Disease Therapeutic:Analyses of BACE1 and GSK-3βInhibitory Activities
2
作者 Chan Hum Park Min Jo Kim +3 位作者 Hyun Ah Jung Jae Sue Choi Jin Pyeong Jeon Takako Yokozawa 《Journal of Integrative Medicine(双语)》 2021年第2期37-42,共6页
Inhibition ofβ-site amyloid precursor protein-cleaving enzyme 1(BACE1)or glycogen synthase kinase-3β(GSK-3β)is estimated to be the central therapeutic approach for Alzheimer’s disease(AD).In this study,water extra... Inhibition ofβ-site amyloid precursor protein-cleaving enzyme 1(BACE1)or glycogen synthase kinase-3β(GSK-3β)is estimated to be the central therapeutic approach for Alzheimer’s disease(AD).In this study,water extract of Kangenkaryu,its crude drug and chemical composition used in oriental medicine were evaluated regarding their BACE1 and GSK-3βinhibitory activities.Fluorescence resonance energy transfer was used to characterize the BACE1 inhibitory effect of Kangen-karyu,its crude drug and chemical composition.GSK-3βactivity was determined using the Kinase-Glo Luminescent Kinase Assay Platform.The water extract of Kangen-karyu inhibited BACE1 and GSK-3βin concentration-dependent manners when compared with reference drugs,quercetin and luteolin.Among six components of Kangen-karyu,the water extracts of Salviae Miltiorrhizae Radix or Cyperi Rhizoma exhibited significant inhibitory effects on BACE1 and GSK-3β.Among the constituents of Salviae Miltiorrhizae Radix extract,salvianolic acid C,salvianolic acid A,rosmarinic acid,and magnesium lithospermate B significantly inhibited BACE1.In addition,they inhibited GSK-3βwith an IC50 value range of 6.97 to 135.35μM.From these results,one of the effectiveness and its mechanisms of action of Kangen-karyu against AD may be the inhibition of BACE1 and GSK-3β,and one of the active ingredients of Kangen-karyu is Salviae Miltiorrhizae Radix and its constituents. 展开更多
关键词 Alzheimer’s disease β-Site amyloid precursor protein-cleaving enzyme 1 Glycogen synthase kinase-3β kangen-karyu Salviae Miltiorrhizae Radix Salvianolic acid C Salvianolic acid B
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部